[M03AB01, succinylcholine, Succinylcholine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01EC01, sulfamethoxazole, The metabolism of Suvorexant can be decreased when combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Suvorexant can be increased when combined with Sulfinpyrazone.]
[N05AL01, sulpiride, Sulpiride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX03, sulthiame, Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Suvorexant.]
[N05CD07, temazepam, Temazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Suvorexant.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Suvorexant.]
[G03BA03, testosterone, The metabolism of Suvorexant can be increased when combined with Testosterone.]
[N07XX06, tetrabenazine, The risk or severity of sedation and somnolence can be increased when Suvorexant is combined with Tetrabenazine.]
[S01HA03, tetracaine, Tetracaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S03AA02, tetracycline, The metabolism of Suvorexant can be decreased when combined with Tetracycline.]
[N05AE05, lurasidone, Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BC07, apomorphine, Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AX02, thalidomide, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Suvorexant.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Suvorexant.]
[N05CA19, thiopental, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AB08, thioproperazine, Thioproperazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AC02, thioridazine, Thioridazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AF04, thiothixene, Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AL03, tiapride, Tiapride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AX01, tilidine, Tilidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03BX04, tolperisone, Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AX02, tramadol, Tramadol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX05, trazodone, Trazodone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01BA05, triamcinolone, The metabolism of Suvorexant can be increased when combined with Triamcinolone.]
[N05CD05, triazolam, Triazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AB12, mepenzolate, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AD02, trifluperidol, Trifluperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AA05, triflupromazine, Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04AA01, trihexyphenidyl, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The metabolism of Suvorexant can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AC02, trimethadione, Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA06, trimipramine, Trimipramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AX07, triprolidine, Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03BB01, butylscopolamine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Suvorexant can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX02, tryptophan, Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03AA02, tubocurarine, Tubocurarine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R03DX07, roflumilast, The metabolism of Suvorexant can be decreased when combined with Roflumilast.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Suvorexant.]
[A10BH05, linagliptin, The metabolism of Suvorexant can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Suvorexant can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Suvorexant can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Suvorexant can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[B01AF01, rivaroxaban, The serum concentration of Rivaroxaban can be increased when it is combined with Suvorexant.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Suvorexant.]
[B01AC24, ticagrelor, The serum concentration of Ticagrelor can be increased when it is combined with Suvorexant.]
[C08DA01, verapamil, The metabolism of Suvorexant can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Suvorexant.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Suvorexant.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Suvorexant.]
[A11HA03, vitamin E, The metabolism of Suvorexant can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Suvorexant.]
[N05AF05, zuclopenthixol, Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AE02, indinavir, The metabolism of Suvorexant can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EC01, vemurafenib, The serum concentration of Vemurafenib can be increased when it is combined with Suvorexant.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Suvorexant.]
[L01ED01, crizotinib, The serum concentration of Crizotinib can be increased when it is combined with Suvorexant.]
[R03DC01, zafirlukast, The metabolism of Suvorexant can be decreased when combined with Zafirlukast.]
[N05AE04, ziprasidone, Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G03AC10, drospirenone, The metabolism of Suvorexant can be decreased when combined with Drospirenone.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Suvorexant.]
[G04BD07, tolterodine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[J02AC03, voriconazole, The metabolism of Suvorexant can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, Atracurium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01FA01, atropine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Suvorexant.]
[R07AX02, ivacaftor, The metabolism of Suvorexant can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Suvorexant can be increased when combined with Prednylidene.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Suvorexant.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Suvorexant.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A08AA11, lorcaserin, Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G04BD12, mirabegron, The serum concentration of Mirabegron can be increased when it is combined with Suvorexant.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be increased when it is combined with Suvorexant.]
[V03AX03, cobicistat, The metabolism of Suvorexant can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Suvorexant can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Suvorexant can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Suvorexant.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be increased when it is combined with Suvorexant.]
[N05CA04, barbital, Barbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AE04, nelfinavir, The metabolism of Suvorexant can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Suvorexant.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BD02, rasagiline, Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03FA09, mosapride, Mosapride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06DA02, donepezil, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CC03, zolmitriptan, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AC06, thonzylamine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, Diethyl ether may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H01CB05, pasireotide, The metabolism of Suvorexant can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The serum concentration of Sildenafil can be increased when it is combined with Suvorexant.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Suvorexant.]
[B01AF02, apixaban, The serum concentration of Apixaban can be increased when it is combined with Suvorexant.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Suvorexant.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Suvorexant can be increased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AD07, benperidol, Benperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A10BK02, canagliflozin, The serum concentration of Canagliflozin can be increased when it is combined with Suvorexant.]
[A06AX06, tegaserod, The serum concentration of Tegaserod can be increased when it is combined with Suvorexant.]
[R02AD01, benzocaine, Benzocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CC02, naratriptan, Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AA18, everolimus, The serum concentration of Everolimus can be increased when it is combined with Suvorexant.]
[N04AC01, benztropine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Suvorexant can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Suvorexant.]
[N06AX28, levomilnacipran, Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be increased when it is combined with Suvorexant.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Suvorexant.]
[N06AX26, vortioxetine, Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AF04, eslicarbazepine, Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AP05, simeprevir, The metabolism of Suvorexant can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be increased when it is combined with Suvorexant.]
[N03AG04, vigabatrin, Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CH03, tasimelteon, Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AA07, metreleptin, The metabolism of Suvorexant can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Suvorexant can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Suvorexant can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Suvorexant can be increased when combined with Betamethasone.]
[L04AC11, siltuximab, The metabolism of Suvorexant can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Suvorexant.]
[B01AC26, vorapaxar, The metabolism of Suvorexant can be decreased when combined with Vorapaxar.]
[A03BA03, hyoscyamine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Suvorexant.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Suvorexant.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Suvorexant.]
[N01AX05, alfaxalone, Alfaxalone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[D11AA01, glycopyrronium, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[S01AA13, fusidic acid, The metabolism of Suvorexant can be decreased when combined with Fusidic acid.]
[J01XA05, oritavancin, The metabolism of Suvorexant can be increased when combined with Oritavancin.]
[N05AA04, acepromazine, Acepromazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Suvorexant.]
[N04AA02, biperiden, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L01EX09, nintedanib, The serum concentration of Nintedanib can be increased when it is combined with Suvorexant.]
[J05AP09, dasabuvir, The serum concentration of Dasabuvir can be increased when it is combined with Suvorexant.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Suvorexant.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Suvorexant.]
[N06AX11, mirtazapine, Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AC10, secukinumab, The metabolism of Suvorexant can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Suvorexant.]
[L01EX08, lenvatinib, The serum concentration of Lenvatinib can be increased when it is combined with Suvorexant.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Suvorexant.]
[N02BE01, acetaminophen, The metabolism of Suvorexant can be increased when combined with Acetaminophen.]
[A03AA09, difemerine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[J05AP06, asunaprevir, The metabolism of Suvorexant can be increased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Suvorexant.]
[G02CX02, flibanserin, Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AX15, cariprazine, Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01EC01, acetazolamide, Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AB07, acetophenazine, Acetophenazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Suvorexant.]
[J02AC05, isavuconazole, The metabolism of Suvorexant can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Suvorexant.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Suvorexant.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Suvorexant.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Suvorexant.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Suvorexant.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Suvorexant.]
[M04AB05, lesinurad, The metabolism of Suvorexant can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, The serum concentration of Elbasvir can be increased when it is combined with Suvorexant.]
[J05AP11, grazoprevir, The serum concentration of Grazoprevir can be increased when it is combined with Suvorexant.]
[N05CA05, aprobarbital, Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX23, brivaracetam, Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be increased when it is combined with Suvorexant.]
[N05BA08, bromazepam, Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BC01, bromocriptine, Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AX08, alverine, Alverine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AB01, brompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA19, amineptin, Amineptine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AX17, pimavanserin, The metabolism of Suvorexant can be decreased when combined with Pimavanserin.]
[N06BX11, aniracetam, Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01BB01, bupivacaine, Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N07BC01, buprenorphine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, Buspirone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Suvorexant.]
[N02AF01, butorphanol, Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01GX07, azelastine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Suvorexant can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Suvorexant can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Suvorexant can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The risk or severity of sedation and somnolence can be increased when Suvorexant is combined with Deutetrabenazine.]
[N02BF02, pregabalin, Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX30, beclamide, Beclamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01HA02, benoxinate, Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[D05AX03, calcitriol, The metabolism of Suvorexant can be increased when combined with Calcitriol.]
[J05AE09, tipranavir, The metabolism of Suvorexant can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The metabolism of Suvorexant can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Suvorexant can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Suvorexant.]
[N04BD03, safinamide, Safinamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AC14, sarilumab, The metabolism of Suvorexant can be increased when combined with Sarilumab.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Suvorexant.]
[D01AC10, bifonazole, The metabolism of Suvorexant can be decreased when combined with Bifonazole.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Suvorexant.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Suvorexant.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Suvorexant.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Suvorexant.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Suvorexant.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Suvorexant.]
[J05AG03, efavirenz, Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04AA11, bornaprine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CD09, brotizolam, Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R03BA02, budesonide, The metabolism of Suvorexant can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Suvorexant.]
[N05CA03, butobarbital, Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AX18, letermovir, The metabolism of Suvorexant can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C01AA02, acetyldigoxins, Suvorexant may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[N01BX04, capsaicin, The metabolism of Suvorexant can be decreased when combined with Capsaicin.]
[A10BK04, ertugliflozin, The serum concentration of Ertugliflozin can be increased when it is combined with Suvorexant.]
[N05CA08, butylvinal, Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L02BB05, apalutamide, The metabolism of Suvorexant can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AA03, camylofine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, Carbinoxamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[B02BX09, fostamatinib, The metabolism of Suvorexant can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[B02BX08, avatrombopag, The serum concentration of Avatrombopag can be increased when it is combined with Suvorexant.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Suvorexant.]
[H01CC03, elagolix, The serum concentration of Elagolix can be increased when it is combined with Suvorexant.]
[L01XX62, ivosidenib, The metabolism of Suvorexant can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Suvorexant.]
[J05AX24, tecovirimat, The metabolism of Suvorexant can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The serum concentration of Duvelisib can be increased when it is combined with Suvorexant.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be increased when it is combined with Suvorexant.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Suvorexant.]
[S01GX12, cetirizine, Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CM04, carbromal, Carbromal may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01BA04, chloroprocaine, Chloroprocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AA06, chlorphenoxamine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Suvorexant.]
[M03BA02, carisoprodol, Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R03BB08, revefenacin, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01ED05, lorlatinib, The metabolism of Suvorexant can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Suvorexant can be increased when combined with Emapalumab.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Suvorexant.]
[L01EX13, gilteritinib, The serum concentration of Gilteritinib can be increased when it is combined with Suvorexant.]
[L01XJ03, glasdegib, The serum concentration of Glasdegib can be increased when it is combined with Suvorexant.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Suvorexant.]
[A03FA08, cinitapride, Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[P02BX04, triclabendazole, The metabolism of Suvorexant can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, Esketamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Suvorexant.]
[J01FA09, clarithromycin, The metabolism of Suvorexant can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Solriamfetol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX29, brexanolone, Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Suvorexant.]
[N05BA09, clobazam, Clobazam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H02AB14, cloprednol, The metabolism of Suvorexant can be increased when combined with Cloprednol.]
[N05BA22, cloxazolam, Cloxazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AB01, etanercept, The metabolism of Suvorexant can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Suvorexant can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Suvorexant.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Suvorexant.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Suvorexant.]
[N05AA06, cyamemazine, Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EJ02, fedratinib, The serum concentration of Fedratinib can be increased when it is combined with Suvorexant.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Suvorexant.]
[N07XX11, pitolisant, The serum concentration of Suvorexant can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Suvorexant can be decreased when combined with Pretomanid.]
[J01XX12, lefamulin, Suvorexant may decrease the excretion rate of Lefamulin which could result in a higher serum level.]
[G04BE04, yohimbine, Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Suvorexant.]
[J01DB01, cephalexin, The metabolism of Suvorexant can be decreased when combined with Cephalexin.]
[J01DB09, cephradine, The metabolism of Suvorexant can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Suvorexant can be increased when combined with Deflazacort.]
[N02CC08, lasmiditan, Lasmiditan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Suvorexant.]
[N03AX25, cenobamate, The serum concentration of Suvorexant can be decreased when it is combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Suvorexant.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Suvorexant.]
[R06AB06, dexbrompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AX03, dezocine, Dezocine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CM21, lemborexant, Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01XX72, tazemetostat, The serum concentration of Tazemetostat can be increased when it is combined with Suvorexant.]
[N05AD10, lumateperone, Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Suvorexant.]
[J05AB16, remdesivir, The metabolism of Suvorexant can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Suvorexant can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Suvorexant can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CC04, dichloralphenazone, Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Suvorexant.]
[A07DA04, difenoxin, Difenoxin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AA08, dihydrocodeine, Dihydrocodeine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CC06, eletriptan, Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M01AH02, rofecoxib, The metabolism of Suvorexant can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Suvorexant can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Suvorexant can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Suvorexant.]
[N03AG02, dipropylacetamide, Valpromide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01FA13, dirithromycin, The metabolism of Suvorexant can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Suvorexant can be decreased when combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Suvorexant.]
[A03AA08, dihexyverine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[D07XB03, fluprednidene, The metabolism of Suvorexant can be increased when combined with Fluprednidene.]
[G04BD09, trospium, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be increased when it is combined with Suvorexant.]
[N05CM02, chlormethiazole, Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03BB02, chlormezanone, Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R02AD04, dyclonine, Dyclonine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Suvorexant.]
[J05AX29, fostemsavir, The serum concentration of Fostemsavir can be increased when it is combined with Suvorexant.]
[N05CD14, remimazolam, Remimazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N07XX04, sodium oxybate, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Suvorexant.]
[L04AC19, satralizumab, The serum concentration of Suvorexant can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Suvorexant is combined with Oliceridine.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Suvorexant.]
[R06AB04, chlorpheniramine, Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AF03, chlorprothixene, Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03BB03, chlorzoxazone, Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BX03, etifoxine, Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06BX18, vinpocetine, Vinpocetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BA18, ethyl loflazepate, Ethyl loflazepate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Suvorexant.]
[A16AX20, lonafarnib, The metabolism of Suvorexant can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Suvorexant.]
[L04AD03, voclosporin, The serum concentration of Voclosporin can be increased when it is combined with Suvorexant.]
[P03AX07, abametapir, The serum concentration of Suvorexant can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Suvorexant.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Suvorexant.]
[M03BA05, febarbamate, Febarbamate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX10, felbamate, Felbamate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R03BA03, flunisolide, The metabolism of Suvorexant can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Suvorexant can be increased when combined with Fluocinolone acetonide.]
[L01EK03, tivozanib, The serum concentration of Tivozanib can be increased when it is combined with Suvorexant.]
[N01AB05, trichloroethylene, Trichloroethylene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Suvorexant.]
[A02BA01, cimetidine, The metabolism of Suvorexant can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01XX73, sotorasib, The serum concentration of Suvorexant can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Suvorexant.]
[S03AA07, ciprofloxacin, The metabolism of Suvorexant can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, Citalopram may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[P01CA03, fexinidazole, The metabolism of Suvorexant can be decreased when combined with Fexinidazole.]
[L04AA59, avacopan, The metabolism of Suvorexant can be decreased when combined with Avacopan.]
[R06AA04, clemastine, Clemastine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX25, St. John's wort extract, St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EA06, asciminib, The metabolism of Suvorexant can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Suvorexant.]
[J04BA01, clofazimine, The metabolism of Suvorexant can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Suvorexant can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Suvorexant can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EJ03, pacritinib, The metabolism of Suvorexant can be decreased when combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Suvorexant.]
[N06AA04, clomipramine, Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AE01, clonazepam, Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Suvorexant.]
[C01EB24, mavacamten, The serum concentration of Suvorexant can be decreased when it is combined with Mavacamten.]
[N05AH06, clothiapine, Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BA21, clotiazepam, Clotiazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A04AA01, ondansetron, Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A04AA02, granisetron, Granisetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AH02, clozapine, Clozapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Suvorexant.]
[N05BA13, halazepam, Halazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H01AC08, somatrogon, The metabolism of Suvorexant can be increased when combined with Somatrogon.]
[S02DA02, cocaine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, Suvorexant may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Suvorexant can be increased when combined with Bimekizumab.]
[R05DA04, codeine, Codeine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03AC05, hexafluorenium, Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Suvorexant.]
[A03AB10, hexocyclium, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[N01AB07, desflurane, Desflurane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A04AA03, tropisetron, Tropisetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C04AX28, ifenprodil, Ifenprodil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01FA15, telithromycin, The metabolism of Suvorexant can be decreased when combined with Telithromycin.]
[R06AX27, desloratadine, Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CC05, almotriptan, Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J02AC02, itraconazole, The metabolism of Suvorexant can be decreased when combined with Itraconazole.]
[N05BA10, ketazolam, Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EA01, imatinib, The metabolism of Suvorexant can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Suvorexant can be decreased when combined with Posaconazole.]
[N03AX09, lamotrigine, Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01GX02, levocabastine, Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01BA03, cortisone, The metabolism of Suvorexant can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Lofexidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CD06, lormetazepam, Lormetazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C08CA11, manidipine, The metabolism of Suvorexant can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, Medifoxamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H02AB15, meprednisone, The metabolism of Suvorexant can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Suvorexant can be decreased when combined with Mequitazine.]
[N04AA03, methixene, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R06AE03, cyclizine, Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CA10, cyclobarbital, Cyclobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AD03, metylperon, Melperone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01FA03, midecamycin, The metabolism of Suvorexant can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Suvorexant.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Suvorexant.]
[N06AX07, minaprine, Minaprine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be increased when it is combined with Suvorexant.]
[N06AG02, moclobemide, Moclobemide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06BA07, modafinil, The metabolism of Suvorexant can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C10AA07, rosuvastatin, The metabolism of Suvorexant can be decreased when combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Suvorexant can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The serum concentration of Vardenafil can be increased when it is combined with Suvorexant.]
[M01AH05, etoricoxib, The metabolism of Suvorexant can be decreased when combined with Etoricoxib.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Suvorexant.]
[G03XA01, danazol, The metabolism of Suvorexant can be decreased when combined with Danazol.]
[M03CA01, dantrolene, Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01DB02, daunorubicin, The metabolism of Suvorexant can be decreased when combined with Daunorubicin.]
[N06BX04, deanol, Deanol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BA16, nordazepam, Nordazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX06, nefazodone, Nefazodone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CM16, niaprazine, Niaprazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AG06, tiagabine, Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03AC11, cisatracurium, Cisatracurium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R05DA06, normethadone, Normethadone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AB10, escitalopram, Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G04BD08, solifenacin, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[N06AA01, desipramine, Desipramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AF02, oxcarbazepine, Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S03BA01, dexamethasone, The metabolism of Suvorexant can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, Oxiracetam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04AA08, dexetimide, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Suvorexant can be increased when combined with Adalimumab.]
[R05DA09, dextromethorphan, Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AC01, paramethadione, Paramethadione may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AC01, dextromoramide, Dextromoramide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AB05, paroxetine, Paroxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N07BC06, heroin, Diamorphine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BA01, diazepam, Diazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX07, phenacemide, Phenacemide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AD02, phensuximide, Phensuximide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA08, dibenzepin, Dibenzepin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S02DA04, dibucaine, Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01CF01, dicloxacillin, The metabolism of Suvorexant can be increased when combined with Dicloxacillin.]
[A03AA07, dicyclomine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[N05AD05, pipamperone, Pipamperone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AB14, pipenzolate, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Suvorexant.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Suvorexant.]
[A08AA03, diethylpropion, Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L02AA01, diethylstilbestrol, The metabolism of Suvorexant can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Suvorexant can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Suvorexant can be increased when combined with Difluocortolone.]
[A03AB11, poldine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Suvorexant.]
[C01AA05, digoxin, Suvorexant may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Suvorexant.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AA03, hydromorphone, Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AE08, atazanavir, The metabolism of Suvorexant can be decreased when combined with Atazanavir.]
[D04AB07, pramoxine, Pramocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C08DB01, diltiazem, The metabolism of Suvorexant can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03BX03, pridinol, Pridinol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AB03, dimethindene, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Suvorexant can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, Progabide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C05CA03, diosmin, The metabolism of Suvorexant can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, Diphenhydramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A07DA01, diphenoxylate, Diphenoxylate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CD10, quazepam, Quazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA23, quinupramine, Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03FA02, cisapride, Cisapride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Suvorexant.]
[N05AL04, remoxipride, Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C01BA03, disopyramide, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[S02AA12, rifamycin SV, The metabolism of Suvorexant can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Suvorexant can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Suvorexant.]
[N07XX02, riluzole, Riluzole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AX08, risperidone, Risperidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AE09, levocetirizine, Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01BB09, ropivacaine, Ropivacaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Suvorexant.]
[A04AD12, aprepitant, The metabolism of Suvorexant can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Suvorexant.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Suvorexant.]
[J05AE07, fosamprenavir, The metabolism of Suvorexant can be decreased when combined with Fosamprenavir.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Suvorexant.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Suvorexant.]
[N06AA16, dothiepin, Dosulepin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA12, doxepin, Doxepin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Suvorexant.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AB06, sertraline, Sertraline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01AB08, sevoflurane, Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A08AA10, sibutramine, Sibutramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C10AA01, simvastatin, The serum concentration of Simvastatin can be increased when it is combined with Suvorexant.]
[N05AL02, sultopride, Sultopride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CC01, sumatriptan, Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Suvorexant.]
[H01AA01, corticotropin, The metabolism of Suvorexant can be increased when combined with Corticotropin.]
[D01BA02, terbinafine, The metabolism of Suvorexant can be increased when combined with Terbinafine.]
[M03BX07, tetrazepam, Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03BX05, thiocolchicoside, Thiocolchicoside may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AB05, thiopropazate, Thiopropazate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G04BD01, emepronium, Emepronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX14, tianeptine, Tianeptine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BA23, tofisopam, Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AG03, toloxatone, Toloxatone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX11, topiramate, Topiramate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L02BA02, toremifene, The serum concentration of Toremifene can be increased when it is combined with Suvorexant.]
[N05CD11, triazulenone, Loprazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CC01, chloral hydrate, Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CM07, triclofos, Triclofos may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AB08, tridihexethyl, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04AA12, tropatepine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, Enflurane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C02CA06, urapidil, Urapidil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AL06, veralipride, Veralipride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Suvorexant.]
[S01GX10, epinastine, Epinastine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX16, venlafaxine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C08CA12, mepirodipine, The metabolism of Suvorexant can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Suvorexant can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX15, zonisamide, Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CF01, zopiclone, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AX11, zotepine, Zotepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C02AC02, guanfacine, Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C01BG01, moricizine, Moricizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G02AB03, ergonovine, Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CA02, ergotamine, Ergotamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01AA17, erythromycin, The metabolism of Suvorexant can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Estazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J04AK02, ethambutol, The metabolism of Suvorexant can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Suvorexant can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Suvorexant can be increased when combined with Fluticasone.]
[N05CM08, ethchlorvynol, Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04AA05, profenamine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AB01, ethotoin, Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01XA06, ethylmorphine, Ethylmorphine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01AX07, etomidate, Etomidate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Suvorexant.]
[N05AE03, sertindole, Sertindole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Suvorexant.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Suvorexant.]
[R06AX12, terfenadine, The metabolism of Suvorexant can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, Bupropion may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AB08, fluvoxamine, Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C10AA03, pravastatin, The serum concentration of Pravastatin can be increased when it is combined with Suvorexant.]
[P02CA03, albendazole, The metabolism of Suvorexant can be decreased when combined with Albendazole.]
[N03AX26, fenfluramine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AB03, fentanyl, Fentanyl may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G04BD02, flavoxate, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[J01CF05, floxacillin, The metabolism of Suvorexant can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Suvorexant can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CD03, flunitrazepam, Flunitrazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[D07AC08, fluocinonide, The metabolism of Suvorexant can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, Melitracen may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H02AB03, fluocortolone, The metabolism of Suvorexant can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, Ethanol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AB03, fluoxetine, Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AF01, flupenthixol, Flupentixol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AB02, fluphenazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CD01, flurazepam, Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AG01, fluspirilene, Fluspirilene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03AA01, alcuronium, Alcuronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G01AX06, furazolidone, Furazolidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AE10, darunavir, The metabolism of Suvorexant can be decreased when combined with Darunavir.]
[N05CF04, eszopiclone, Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AL05, amisulpride, Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03AC02, gallamine, Gallamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AA04, barbexaclone, Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX08, bifemelane, Bifemelane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Suvorexant.]
[N04BC06, cabergoline, Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AG04, etravirine, The metabolism of Suvorexant can be increased when combined with Etravirine.]
[N03AD03, methsuximide, Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01AH02, alfentanil, Alfentanil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EH01, lapatinib, The metabolism of Suvorexant can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Suvorexant can be decreased when combined with Glyburide.]
[N05CM18, dexmedetomidine, Dexmedetomidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CE01, glutethimide, Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Suvorexant.]
[C02CA04, doxazosin, The metabolism of Suvorexant can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Suvorexant.]
[D01BA01, griseofulvin, The metabolism of Suvorexant can be increased when combined with Griseofulvin.]
[N05AD01, haloperidol, Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01AB01, halothane, Halothane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AH04, quetiapine, Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CX03, iprazochrome, Iprazochrome may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Suvorexant.]
[N05CA21, allobarbital, Allobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C09CA01, losartan, The metabolism of Suvorexant can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, The metabolism of Suvorexant can be decreased when combined with Allylestrenol.]
[N05CA16, hexobarbital, Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C08CA10, nilvadipine, The metabolism of Suvorexant can be decreased when combined with Nilvadipine.]
[C02DB02, hydralazine, The metabolism of Suvorexant can be decreased when combined with Hydralazine.]
[R05DA03, hydrocodone, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Suvorexant can be increased when combined with Hydrocortisone.]
[G04BD06, propiverine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[N05AX07, prothipendyl, Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J04AB04, rifabutin, The metabolism of Suvorexant can be increased when combined with Rifabutin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Suvorexant.]
[N01AH03, sufentanil, Sufentanil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA02, imipramine, Imipramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Suvorexant.]
[M03BX02, tizanidine, Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Suvorexant.]
[N06AX17, milnacipran, Milnacipran may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AA30, piperidolate, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, Articaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be increased when it is combined with Suvorexant.]
[N05BA12, alprazolam, Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CH02, ramelteon, Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AE01, buclizine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Suvorexant can be increased when combined with Cerivastatin.]
[C07AA01, alprenolol, Alprenolol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA13, iprindole, Iprindole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AF05, iproniazid, Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AA07, chlorproethazine, Chlorproethazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01AB06, isoflurane, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BX02, entacapone, Entacapone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J04AC01, isoniazid, The metabolism of Suvorexant can be decreased when combined with Isoniazid.]
[N06AX18, reboxetine, Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AC07, tocilizumab, The metabolism of Suvorexant can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Ketamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C02KD01, ketanserin, Ketanserin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J02AB02, ketoconazole, The metabolism of Suvorexant can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Suvorexant can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[V03AC03, deferasirox, The metabolism of Suvorexant can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Suvorexant can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AX18, lacosamide, Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BA01, levodopa, Levodopa may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S02DA01, lidocaine, Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06BA13, armodafinil, The metabolism of Suvorexant can be increased when combined with Armodafinil.]
[N02CA07, lisuride, Lisuride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA07, lofepramine, Lofepramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A07DA03, loperamide, The excretion of Loperamide can be decreased when combined with Suvorexant.]
[N05BA06, lorazepam, Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C10AA02, lovastatin, The metabolism of Suvorexant can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, Loxapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be increased when it is combined with Suvorexant.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Suvorexant can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Suvorexant can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Suvorexant.]
[N06AA21, maprotiline, Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A08AA05, mazindol, Mazindol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AE05, meclizine, Meclizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BA03, medazepam, Medazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C01AA08, medigoxin, Suvorexant may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[P01BC02, mefloquine, The serum concentration of Mefloquine can be increased when it is combined with Suvorexant.]
[N05CH01, melatonin, Melatonin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AB02, meperidine, Meperidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AB04, mephenytoin, Mephenytoin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01BB03, mepivacaine, Mepivacaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BC01, meprobamate, Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AX05, meptazinol, Meptazinol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L02BG01, aminoglutethimide, The metabolism of Suvorexant can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AX13, paliperidone, Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A04AA04, dolasetron, Dolasetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H01CB03, lanreotide, The metabolism of Suvorexant can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Suvorexant.]
[N06BA03, methamphetamine, Metamfetamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AB07, methantheline, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CM01, methaqualone, Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AA30, metharbital, Metharbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G02CB05, metergoline, Metergoline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H03BB02, methimazole, The metabolism of Suvorexant can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CA15, methohexital, Methohexital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02BG08, ziconotide, Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Suvorexant.]
[N05AA02, methotrimeprazine, Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02BG09, methoxyflurane, Methoxyflurane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[V04CG05, methylene blue, Methylene blue may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G02AB01, methylergonovine, The metabolism of Suvorexant can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Suvorexant.]
[H02AB04, methylprednisolone, The metabolism of Suvorexant can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CE02, methyprylon, Methyprylon may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CA04, methysergide, Methysergide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Suvorexant.]
[P01AB01, metronidazole, The metabolism of Suvorexant can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Suvorexant can be increased when combined with Metyrapone.]
[N06AX03, mianserin, Mianserin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S02AA13, miconazole, The metabolism of Suvorexant can be decreased when combined with Miconazole.]
[N05CD08, midazolam, Midazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G03XB01, mifepristone, The metabolism of Suvorexant can be increased when combined with Mifepristone.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01FA11, miocamycin, The metabolism of Suvorexant can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Suvorexant can be increased when combined with Mitotane.]
[N05AE02, molindone, Molindone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L03AC01, aldesleukin, The metabolism of Suvorexant can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Suvorexant can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AA01, morphine, Morphine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A04AA05, palonosetron, Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AB05, certolizumab pegol, The metabolism of Suvorexant can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Suvorexant.]
[M03AC03, vecuronium, Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CA02, amobarbital, Amobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Suvorexant.]
[R03BB01, ipratropium bromide, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[G03XC01, raloxifene, The metabolism of Suvorexant can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AB05, fosphenytoin, Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BC04, ropinirole, Suvorexant may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The metabolism of Suvorexant can be increased when combined with Nafcillin.]
[C04AX21, nafronyl, Naftidrofuryl may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AF02, nalbuphine, Nalbuphine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[V03AB15, naloxone, The metabolism of Suvorexant can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Suvorexant can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of CNS depression can be increased when Naphazoline is combined with Suvorexant.]
[A10BG01, troglitazone, The metabolism of Suvorexant can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BX01, tolcapone, Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Suvorexant.]
[N01AH06, remifentanil, Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AX14, iloperidone, Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX23, desvenlafaxine, Desvenlafaxine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C10AD02, niacin, The metabolism of Suvorexant can be decreased when combined with Niacin.]
[N06AF02, nialamide, Nialamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C08CA04, nicardipine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.]
[N05CD02, nitrazepam, Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CF03, zaleplon, Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BC05, pramipexole, Suvorexant may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AX04, nomifensine, Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G03DC02, norethindrone, The metabolism of Suvorexant can be decreased when combined with Norethisterone.]
[C02KX01, bosentan, The metabolism of Suvorexant can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R05DA07, noscapine, The metabolism of Suvorexant can be decreased when combined with Noscapine.]
[H01CB02, octreotide, The metabolism of Suvorexant can be decreased when combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Suvorexant can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Suvorexant can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Suvorexant can be increased when combined with Omeprazole.]
[N06AA05, opipramol, Opipramol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AA02, opium, Opium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BA04, oxazepam, Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C07AA02, oxprenolol, Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AA05, oxycodone, Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AA11, oxymorphone, Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AE01, oxypertine, Oxypertine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AB03, oxyphenonium, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, Asenapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03AC01, pancuronium, Pancuronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CC05, paraldehyde, Paraldehyde may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H02AB05, paramethasone, The metabolism of Suvorexant can be increased when combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[G04BD11, fesoterodine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, Penbutolol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AG03, penfluridol, Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AD01, pentazocine, Pentazocine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CA01, pentobarbital, Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AB10, perazine, Perazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BC02, pergolide, Pergolide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AB03, perphenazine, Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AD02, phenazocine, Phenazocine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AF03, phenelzine, Phenelzine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N03AA02, phenobarbital, Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01AH04, phenoperidine, Phenoperidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Suvorexant.]
[M02AA01, phenylbutazone, The metabolism of Suvorexant can be increased when combined with Phenylbutazone.]
[N03AB02, phenytoin, Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AB06, golimumab, The metabolism of Suvorexant can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Suvorexant.]
[C08CX01, mibefradil, The serum concentration of Mibefradil can be increased when it is combined with Suvorexant.]
[N05AG02, pimozide, Pimozide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C07AA03, pindolol, Pindolol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AE01, saquinavir, The metabolism of Suvorexant can be decreased when combined with Saquinavir.]
[N05AC04, pipothiazine, Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A02BX03, pirenzepine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, Piritramide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CX01, pizotyline, Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J05AG02, delavirdine, The metabolism of Suvorexant can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Suvorexant can be decreased when combined with Irbesartan.]
[N05CA22, proxibarbal, Proxibarbal may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AE01, alosetron, Alosetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L04AC08, canakinumab, The metabolism of Suvorexant can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Suvorexant can be increased when it is combined with Ritonavir.]
[N05BA11, prazepam, Prazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S03BA02, prednisolone, The metabolism of Suvorexant can be increased when combined with Prednisolone.]
[N01BB04, prilocaine, Prilocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[P01BA03, primaquine, The metabolism of Suvorexant can be decreased when combined with Primaquine.]
[N03AA03, primidone, Primidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M04AB01, probenecid, The metabolism of Suvorexant can be increased when combined with Probenecid.]
[S01HA05, procaine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01XB01, procarbazine, Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C10AB05, fenofibrate, The metabolism of Suvorexant can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04AA04, procyclidine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[N05AA03, promazine, Promazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AD02, promethazine, Promethazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N01AX04, propanidid, Propanidid may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AB05, propantheline, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Suvorexant.]
[N05AC01, periciazine, Periciazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CM06, propiomazine, Propiomazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Suvorexant.]
[N01AX10, propofol, Propofol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02AC04, propoxyphene, Dextropropoxyphene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N02CC04, rizatriptan, Rizatriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N06AA11, protriptyline, Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05AX12, aripiprazole, Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A03AB15, diphemanil, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, Talbutal may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CA09, vinbarbital, Vinbarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05BB02, captodiamine, Captodiame may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[M03BA04, styramate, Styramate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[P02CC01, pyrantel, Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[R06AC01, pyrilamine, Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C01BA01, quinidine, The serum concentration of Quinidine can be increased when it is combined with Suvorexant.]
[P01BC01, quinine, Quinine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[C02AA02, reserpine, Reserpine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J04AB02, rifampin, The metabolism of Suvorexant can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01FA06, roxithromycin, The metabolism of Suvorexant can be decreased when combined with Roxithromycin.]
[S01FA02, scopolamine, Scopolamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N05CA06, secobarbital, Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[N04BD01, selegiline, Selegiline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[H01CB01, somatostatin, The metabolism of Suvorexant can be decreased when combined with Somatostatin.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Suvorexant.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Suvorexant.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Suvorexant.]
[N03AG01, valproic acid, Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[D07AB02, hydrocortisone butyrate, The metabolism of Suvorexant can be increased when combined with Hydrocortisone butyrate.]
